Alzheimer's disease and other dementias: advances in 2014
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical)
Reference17 articles.
1. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease;Salloway;N Engl J Med,2014
2. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease;Doody;N Engl J Med,2014
3. Cummings J, Cho W, Ward M, et al. A randomized, double-blind, placebo-controlled phase 2 study to evaluate the efficacy and safety of crenezumab in patients with mild to moderate Alzheimer's disease. Alzheimer's Association International Conference; Copenhagen, Denmark, July 11–17, 2014.
4. The novel BACE inhibitor MK-8931 dramatically lowers CSF beta-amyloid in patients with mild-to-moderate Alzheimer's disease;Forman;Alzheimers Dement,2013
5. Alexander R, Budd Haeberlein S, Rosen L, et al. AZD3293 a novel BACE1 inhibitor: pharmacokinetics and effects on plasma and CSF Aβ peptides following multiple-dose administration in Alzheimer's disease patients. Clinical Trials in Alzheimer's Disease Conference; Philadelphia, PA, USA Nov 20–22, 2014. P1–30.
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The knowledge domain of cognitive neuroscience of aging: A Scientometric and bibliometric analysis;Frontiers in Aging Neuroscience;2023-02-09
2. A systematic survey of advances in retinal imaging modalities for Alzheimer’s disease diagnosis;Metabolic Brain Disease;2022-03-15
3. Periodontal Infection Aggravates C1q-Mediated Microglial Activation and Synapse Pruning in Alzheimer’s Mice;Frontiers in Immunology;2022-02-01
4. IntelliCage Automated Behavioral Phenotyping Reveals Behavior Deficits in the 3xTg-AD Mouse Model of Alzheimer’s Disease Associated With Brain Weight;Frontiers in Aging Neuroscience;2021-08-13
5. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies;Acta Neuropathologica;2021-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3